ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.245
      0.16%
      Bitcoin
      57,069.54
      -0.49%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atea Pharmaceuticals Inc (AVIR)

      7. Atea Pharmaceuticals Inc (AVIR) News

      AVIR

      Atea Pharmaceuticals (AVIR)

      Atea Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVIR
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      08/08/20224:05PMGlobeNewswire Inc.Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:AVIRAtea Pharmaceuticals Inc
      08/01/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call on August 8, 2022NASDAQ:AVIRAtea Pharmaceuticals Inc
      07/11/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals Participates in the William Blair Biotech Focus ConferenceNASDAQ:AVIRAtea Pharmaceuticals Inc
      07/05/202211:51PMTipRanksAtea Pharmaceuticals: Share Price Unlikely to Reflect Growth PotentialNASDAQ:AVIRAtea Pharmaceuticals Inc
      06/21/20227:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVIRAtea Pharmaceuticals Inc
      06/21/20225:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVIRAtea Pharmaceuticals Inc
      06/01/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals to Present at the 2022 Jefferies Healthcare ConferenceNASDAQ:AVIRAtea Pharmaceuticals Inc
      05/12/20223:37AMTipRanksSVB Securities Keeps Their Hold Rating on Atea Pharmaceuticals (AVIR)NASDAQ:AVIRAtea Pharmaceuticals Inc
      05/11/20228:11AMTipRanksAtea Pharmaceuticals (AVIR) Receives a Hold from J.P. MorganNASDAQ:AVIRAtea Pharmaceuticals Inc
      05/10/20228:02AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVIRAtea Pharmaceuticals Inc
      05/10/20226:30AMGlobeNewswire Inc.Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:AVIRAtea Pharmaceuticals Inc
      05/03/20224:05PMGlobeNewswire Inc.Atea Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call on May 10, 2022NASDAQ:AVIRAtea Pharmaceuticals Inc
      04/29/20225:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVIRAtea Pharmaceuticals Inc
      03/28/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals Reports Nonclinical Bemnifosbuvir (AT-527) Toxicology Data at Society of Toxicology 61st Annual MeetingNASDAQ:AVIRAtea Pharmaceuticals Inc
      03/02/202211:47AMTipRanksAtea Pharmaceuticals (AVIR) Gets a Hold Rating from J.P. MorganNASDAQ:AVIRAtea Pharmaceuticals Inc
      03/01/20226:06AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/28/20225:40PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/28/20224:48PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/28/20224:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/28/20224:05PMGlobeNewswire Inc.Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateNASDAQ:AVIRAtea Pharmaceuticals Inc
      02/22/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 28, 2022NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/16/20224:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/10/20224:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/10/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals Appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical DevelopmentNASDAQ:AVIRAtea Pharmaceuticals Inc
      02/09/20223:29PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/09/20229:11AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/09/20227:00AMGlobeNewswire Inc.Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:AVIRAtea Pharmaceuticals Inc
      02/04/20224:22PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AVIRAtea Pharmaceuticals Inc
      02/02/20225:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVIRAtea Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:AVIR